Authors
Kechen Qian, Min Sheng, Wenhan Huang, Feifeng Ren, Dandan Chen, Lin Tang
Published in
Clinical and experimental rheumatology. Oct 30, 2026. Epub Oct 30, 2026.
Abstract
To identify predictors of adverse outcomes in hospitalised patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (anti-MDA5+ DM).
We retrospectively analysed data from 113 anti-MDA5+ DM patients during their first hospitalisation, including clinical features, season of onset, high-resolution computed tomography (HRCT) and laboratory results.
Patients presenting primarily with respiratory symptoms had a significantly poorer prognosis than those with skin/muscle symptoms (p<0.05). Onset in winter/spring was associated with higher co-infection rates (p<0.05), and co-infected patients had higher rates of rapidly progressive interstitial lung disease (RP-ILD) or death (p<0.05). Serum lactate dehydrogenase (LDH) levels were significantly higher in patients with RP-ILD or death (p<0.05).
Respiratory symptoms, co-infection, and elevated LDH (≥ 324.5 IU/L) are independent risk factors for RP-ILD or death in anti-MDA5+ DM. For newly hospitalised patients, detailed symptom assessment, prompt infection screening (especially with winter/spring onset) and close LDH monitoring are crucial for prognosis evaluation and guiding clinical management.
PMID:
43001858
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0